Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines

NCT05095298 ·Status: UNKNOWN ·Phase: PHASE4

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

NCT04210349 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

NCT03853993 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

NCT04363359 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of A Quadrivalent Influenza Vaccine

NCT03744104 ·Status: COMPLETED ·Phase: PHASE3

Covid-19 and Influenza Oral Vaccine Study

NCT06355232 ·Status: RECRUITING ·Phase: PHASE1

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05284851 ·Status: UNKNOWN ·Phase: PHASE2

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

NCT05078905 ·Status: RECRUITING

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

NCT04794829 ·Status: RECRUITING

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

NCT06831786 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups

NCT01654809 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population

NCT06597370 ·Status: COMPLETED

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

NCT06694389 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

NCT05313893 ·Status: COMPLETED ·Phase: PHASE4

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

NCT01551810 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

NCT03344029 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

NCT02640989 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

NCT05107375 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

NCT01096225 ·Status: UNKNOWN

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

NCT05138705 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

NCT02710409 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

NCT07332689 ·Status: COMPLETED

Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults

NCT03160118 ·Status: COMPLETED ·Phase: PHASE4

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

NCT03196661 ·Status: COMPLETED ·Phase: PHASE1